Amaxa Overview
- Founded
- 1998
- Status
- Acquired/Merged
- Employees
- 160
- Latest Deal Type
- M&A
- Latest Deal Amount
- $148M
Amaxa General Information
Description
Developer of a Nucleofector device that that is designed to transfer genes for primary cell research where non-viral gene transfer is required.
Contact Information
Primary Office
- Nattermannallee 1
- 50829 Cologne
- Germany
+49 0221 000000
Amaxa Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 02-Jul-2008 | $148M | 000.00 | 00000 | Completed | Product Development |
| 2. Early Stage VC | 13-Jun-2001 | 000.00 | 000.00 | Completed | Product Development | |
| 1. Early Stage VC | Completed |
Amaxa Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAmaxa Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| 3i Group | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Earlybird Venture Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| NRW.Bank | Investment Bank | Minority | 000 0000 | 000000 0 | |
| Technologie-Beteiligungs-Gesellschaft | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Technomedia Kapitalbeteiligungsgesellschaft Koeln | Venture Capital | Minority | 000 0000 | 000000 0 |